Breaking News
Investing Pro 0
Black Friday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday

Stock Markets Sep 14, 2022 09:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
 
IXIC
-0.52%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TGTB34
+3.65%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GREAT
+1.54%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
  • Aditxt, Inc. (NASDAQ: ADTX) jumped 113.8% to close at $0.37.
  • Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) surged 101% to close at $3.86 after a late Monday Form 4 filing showed multiple insider purchases of the stock.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) climbed 79.3% to close at $29.90 on Tuesday as the stock started trading on a 1-for-30 reverse split basis.
  • 89bio, Inc. (NASDAQ: ETNB) shares rose 40% to close at $7.00. Analysts reportedly said Akero's NASH data could be a positive for the company's Pegoza program in NASH.
  • Motorsport Games Inc. (NASDAQ: MSGM) climbed 28.1% to close at $0.97. Motorsport Games, last month, reported worse-than-expected Q2 EPS results.
  • Akouos, Inc. (NASDAQ: AKUS) gained 28% to close at $4.48. The FDA has signed off Akouos Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene therapy for otoferlin gene (OTOF)-mediated hearing loss.
  • Infobird Co., Ltd (NASDAQ: IFBD) jumped 28% to settle at $2.47.
  • Golden Path Acquisition Corporation (NASDAQ: GPCO) rose 22.4% to settle at $8.69.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 22.3% to close at $0.4131.
  • Immuneering Corporation (NASDAQ: IMRX) jumped 22.1% to close at $12.00. Immuneering recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its product candidate IMM-1-104 in development for the treatment of advanced RAS mutant solid tumors.
  • Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) rose 21% to close at $0.2299.
  • VNET Group, Inc. (NASDAQ: VNET) gained 20.7% to close at $5.66 after the company announced the receipt of a preliminary non-binding proposal to acquire all of its shares and formation of a special committee to review the proposal.
  • Cosmos Holdings Inc. (NASDAQ: COSM) climbed 19.7% to settle at $0.4216. Cosmos Health’s subsidiary SkyPharm recently launched its first Sky Premium Life products on Amazon in the U.S.
  • Palisade Bio, Inc. (NASDAQ: PALI) jumped 18.3% to settle at $0.1782. Palisade Bio was Granted U.S. patent titled 'Administration of serine protease inhibitors to the stomach.'
  • Aprea Therapeutics, Inc. (NASDAQ: APRE) gained 17.7% to close at $0.9299.
  • Phunware, Inc. (NASDAQ: PHUN) surged 15.6% to settle at $1.63.
  • NLS Pharmaceutics AG (NASDAQ: NLSP) gained 14.2% to close at $1.12. Laidlaw & Co. recently initiated coverage on NLS Pharmaceutics with a Buy rating and announced a price target of $6.
  • iBio, Inc. (NYSE: IBIO) rose 13.7% to close at $0.3080 after declining over 4% on Monday.
  • Planet Labs PBC (NYSE: PL) gained 13.5% to close at $6.15 after the company reported better-than-expected Q2 results and raised guidance.
  • Aehr Test Systems (NASDAQ: AEHR) gained 13.5% to close at $15.99 after the company received a wafer level burn-in system order.
  • HilleVax, Inc. (NASDAQ: HLVX) rose 12.4% to close at $22.01.
  • Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 12.1% to close at $0.8914. The company earlier reported initial drill results from its 2022-2023 exploration program.
  • Entrada Therapeutics, Inc. (NASDAQ: TRDA) surged 10.3% to settle at $13.14.
  • Tyme Technologies, Inc. (NASDAQ: TYME) gained 9.1% to close at $0.2807 after gaining around 4% on Monday.
  • V2X, Inc. (NYSE: VVX) gained 8.6% to close at $41.25.
  • LSB Industries, Inc. (NYSE: LXU) gained 6.3% to close at $17.04. Piper Sandler initiated coverage on LSB Industries with an Overweight rating and announced a price target of $26.
  • Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares rose 4.9% to close at $0.7659 after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer.
  • Core & Main, Inc. (NYSE: CNM) rose 2.5% to close at $25.11 following upbeat Q2 results.
Losers
  • Cardiff Oncology, Inc. (NASDAQ: CRDF) shares dipped 41.1% to close at $1.89 on Tuesday. Following a strategic review, Cardiff Oncology decided it will not independently fund any future clinical activities in metastatic castrate-resistant prostate cancer (mCRPC), citing clinical data and therapeutic landscape.
  • Rent the Runway, Inc. (NASDAQ: RENT) shares dropped 38.7% to close at $3.02 after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. Credit Suisse (SIX:CSGN) downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) fell 35.7% to close at $12.07. InMed Pharmaceuticals recently announced a $6 million private placement priced at $8.68 per share.
  • Codiak BioSciences, Inc. (NASDAQ: CDAK) dipped 33.5% to close at $1.11 after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant.
  • Benitec Biopharma Inc. (NASDAQ: BNTC) declined 28.3% to close at $0.4550 as the company reported pricing of $18 million underwritten public offering.
  • Edgewise Therapeutics, Inc. (NASDAQ: EWTX) dropped 24% to settle at $10.32. Edgewise Therapeutics announced a proposed $100 million offering of common stock.
  • Nocera, Inc. (NASDAQ: NCRA) fell 22.5% to close at $1.96.
  • Venus Concept Inc. (NASDAQ: VERO) dropped 21.5% to close at $0.5508.
  • AMTD Digital Inc. (NYSE: HKD) declined 21.1% to close at $46.00.
  • Braze, Inc. (NASDAQ: BRZE) fell 19.3% to close at $35.18 after the company reported Q2 earnings results and issued Q3 2023 adjusted EPS guidance below estimates.
  • PolyPid Ltd. (NASDAQ: PYPD) fell 18.7% to settle at $1.39 after jumping 58% on Monday. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
  • Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) dropped 17.8% to close at $7.11.
  • Relay Therapeutics, Inc. (NASDAQ: RLAY) shares fell 16.6% to close at $24.03. Relay Therapeutics priced 11.32 million share public offering of common stock at $26.50 per share.
  • Soluna Holdings, Inc. (NASDAQ: SLNH) fell 15.6% to close at $2.66.
  • Hut 8 Mining Corp. (NASDAQ: HUT) dipped 15.4% to settle at $2.03.
  • Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) dropped 15.2% to close at $26.45.
  • Jasper Therapeutics, Inc. (NASDAQ: JSPR) fell 15.1% to settle at $1.58.
  • Boxed, Inc. (NYSE: BOXD) declined 14.8% to settle at $0.9283.
  • Kingsoft Cloud Holdings Limited (NASDAQ: KC) fell 14.4% to close at $2.26.
  • Innovid Corp. (NYSE: CTV) fell 14.2% to close at $3.08. Morgan Stanley (NYSE:MS) initiated coverage on Innovid with an Underweight rating and announced a price target of $2.7.
  • The RealReal, Inc. (NASDAQ: REAL) declined 14.1% to close at $2.26.
  • Magic Empire Global Limited (NASDAQ: MEGL) dropped 14% to close at $5.16.
  • Syneos Health, Inc. (NASDAQ: SYNH) fell 13.7% to settle at $54.72.
  • LumiraDx Limited (NASDAQ: LMDX) declined 13.6% to settle at $1.33.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) fell 13.4% to close at $0.9270 after the company discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
  • The Children's Place, Inc. (NASDAQ: PLCE) declined 13.4% to settle at $35.17.
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) slipped 13.4% to close at $13.91.
  • Unity Software Inc. (NYSE: U) dropped 13.4% to close at $36.66 after Applovin announced it does not intend to submit another proposal to combine with the company and has withdrawn its Aug. 9 proposal.
  • Carvana Co. (NYSE: CVNA) fell 12.9% to close at $36.81.
  • MicroStrategy Incorporated (NASDAQ: MSTR) dropped 12.1% to close at $231.25 after August CPI data showed greater-than-expected US inflation.
  • WalkMe Ltd. (NASDAQ: WKME) declined 11.9% to close at $9.74. WalkMe announced the departure of Chief Financial Officer Andrew Casey.
  • Pacific Biosciences of California, Inc. (NASDAQ: PACB) dipped 11.7% to close at $6.14.
  • Asana, Inc. (NYSE: ASAN) fell 11.5% to close at $25.42.
  • Wayfair Inc. (NYSE: W) fell 11.1% to close at $49.76.
  • Upstart (NASDAQ:UPST) Holdings, Inc. (NASDAQ: UPST) fell 10.9% to close at $24.97.
  • Peloton (NASDAQ:PTON) Interactive, Inc. (NASDAQ: PTON) fell 10.3% to close at $9.91 after the company announced Executive Chair John Foley will step down, effective Sept. 12. Karen Boone has been elected Chairperson of the Board.
  • BridgeBio Pharma, Inc. (NASDAQ: BBIO) fell 10.1% to close at $11.11.
  • Crocs, Inc. (NASDAQ: CROX) dropped 9.8% to settle at $75.39 amid overall market weakness as August CPI readings showed inflation came in greater than expected.
  • NVIDIA Corporation (NASDAQ: NASDAQ:NVDA) tumbled 9.5% to close at $131.31. Shares of semiconductor stocks at large traded lower after August CPI data showed greater-than-expected US inflation, which has caused economic concerns and raised expectations for aggressive Fed policy. Fed rate hikes could drive a slowdown in the economy, which could pressure demand in semiconductor and chip end markets.
  • Tuesday Morning Corporation (NASDAQ: TUEM) fell 8.8% to close at $0.1766. The company recently announced it has entered into an agreement to secure $32 million in convertible debt financing.
  • Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) declined 8.8% to settle at $75.25 as cryptocurrencies fell following worse-than-expected US inflation data.
  • Amazon.com, Inc. (NASDAQ: NASDAQ:AMZN) dipped 7.1% to close at $126.82 after August CPI data showed greater-than-expected US inflation.
  • AppLovin Corporation (NASDAQ: APP) fell 6.4% to close at $26.68. Applovin announced it does not intend to submit another proposal to combine with Unity Software and has withdrawn its Aug. 9 proposal.
  • Apple Inc. (NASDAQ: NASDAQ:AAPL) fell 5.9% to close at $153.84 amid overall market weakness after August CPI readings showed inflation came in greater than expected.
  • Microsoft Corporation (NASDAQ: NASDAQ:MSFT) fell 5.5% to settle at $251.99 after August CPI data showed greater-than-expected US inflation.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email